Literature DB >> 20096134

Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart disease.

Sigurdur S Stephensen1, Marcus Carlsson, Martin Ugander, Henrik Engblom, Goran Olivecrona, David Erlinge, Hakan Arheden.   

Abstract

BACKGROUND: Left ventricular mass (LVM) is used when expressing infarct or fibrosis as a percentage of the left ventricle (LV). Quantification of LVM is interchangeably carried out in cine steady state free precession (SSFP) and delayed enhancement (DE) magnetic resonance imaging (MRI). However, these techniques may yield different LVM. Therefore, the aim of the study was to compare LVM determined by SSFP and DE MRI in patients and determine the agreement with these sequences with ex vivo data in an experimental animal model.
METHODS: Ethics committees approved human and animal studies. Informed written consent was obtained from all patients. SSFP and DE images were acquired in 60 patients (20 with infarction, 20 without infarction and 20 pediatric patients). Ex vivo MRI was used as reference method for LVM in 19 pigs and compared to in vivo SSFP and DE.
RESULTS: LVM was greater in SSFP than in DE (p < 0.001) with a bias of 5.0 +/- 6.7% in humans (r2 = 0.98), and a bias of 7.3 +/- 6.7% (p < 0.001) in pigs (r2 = 0.83). Bias for SSFP and DE images compared to ex vivo LVM was -0.2 +/- 9.0% and -7.7 +/- 8.5% respectively.
CONCLUSIONS: LVM was higher when measured with SSFP compared to DE. Thus, the percentage infarction of the LV will differ if SSFP or DE is used to determine LVM. There was no significant difference between SSFP and ex vivo LVM suggesting that SSFP is more accurate for LVM quantification. To avoid intrinsic error due to the differences between the sequences, we suggest using DE when expressing infarct as a percentage of LVM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096134      PMCID: PMC2881013          DOI: 10.1186/1471-2342-10-4

Source DB:  PubMed          Journal:  BMC Med Imaging        ISSN: 1471-2342            Impact factor:   1.930


  30 in total

1.  Progressive ventricular remodeling in rat with myocardial infarction.

Authors:  J M Pfeffer; M A Pfeffer; P J Fletcher; E Braunwald
Journal:  Am J Physiol       Date:  1991-05

2.  Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance.

Authors:  A M Maceira; S K Prasad; M Khan; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

3.  Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome.

Authors:  Sonya V Babu-Narayan; Philip J Kilner; Wei Li; James C Moon; Omer Goktekin; Periklis A Davlouros; Mohammed Khan; Siew Yen Ho; Dudley J Pennell; Michael A Gatzoulis
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

Review 4.  The right ventricle in congenital heart disease.

Authors:  P A Davlouros; K Niwa; G Webb; M A Gatzoulis
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

5.  Quantitation of infarct size in patients with chronic coronary artery disease using rest-redistribution Tl-201 myocardial perfusion SPECT: correlation with contrast-enhanced cardiac magnetic resonance.

Authors:  David S Fieno; Louise E J Thomson; Piotr Slomka; Aiden Abidov; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

6.  Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract.

Authors:  Thomas Oosterhof; Barbara J M Mulder; Hubert W Vliegen; Albert de Roos
Journal:  Radiology       Date:  2005-12       Impact factor: 11.105

7.  Simultaneous and correlated detection of endocardial and epicardial borders on short-axis MR images for the measurement of left ventricular mass.

Authors:  P Balzer; A Furber; C Cavaro-Ménard; A Croué; A Tadéi; P Geslin; P Jallet; J J Le Jeune
Journal:  Radiographics       Date:  1998 Jul-Aug       Impact factor: 5.333

8.  Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.

Authors:  Olga Bondarenko; Aernout M Beek; Mark B M Hofman; Harald P Kühl; Jos W R Twisk; Willem G van Dockum; Cees A Visser; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

Review 9.  Delayed enhancement MR imaging: utility in myocardial assessment.

Authors:  Jens Vogel-Claussen; Carlos E Rochitte; Katherine C Wu; Ihab R Kamel; Thomas K Foo; João A C Lima; David A Bluemke
Journal:  Radiographics       Date:  2006 May-Jun       Impact factor: 5.333

10.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

Authors:  M St John Sutton; M A Pfeffer; L Moye; T Plappert; J L Rouleau; G Lamas; J Rouleau; J O Parker; M O Arnold; B Sussex; E Braunwald
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

View more
  5 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

2.  Quantitative analysis of cardiac left ventricular variables obtained by MRI at 3 T: a pre- and post-contrast comparison.

Authors:  S Matthew; S J Gandy; R S Nicholas; S A Waugh; E A Crowe; R A Lerski; M H Dunn; J G Houston
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

Review 3.  Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

Authors:  Jeremy Earl Brooks; Elsayed Z Soliman; Bharathi Upadhya
Journal:  Curr Hypertens Rep       Date:  2019-05-20       Impact factor: 5.369

4.  Ex vivo cardiovascular magnetic resonance measurements of right and left ventricular mass compared with direct mass measurement in excised hearts after transplantation: a first human SSFP comparison.

Authors:  Nicholas J Farber; Sahadev T Reddy; Mark Doyle; Geetha Rayarao; Diane V Thompson; Peter Olson; Jerry Glass; Ronald B Williams; June A Yamrozik; Srinivas Murali; Robert Ww Biederman
Journal:  J Cardiovasc Magn Reson       Date:  2014-10-01       Impact factor: 5.364

5.  Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo.

Authors:  Robert Jablonowski; David Nordlund; Mikael Kanski; Joey Ubachs; Sasha Koul; Einar Heiberg; Henrik Engblom; David Erlinge; Håkan Arheden; Marcus Carlsson
Journal:  BMC Cardiovasc Disord       Date:  2013-12-05       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.